The Fiji Centre of Disease Control (CDC) has confirmed that the influenza-like illness in predominant circulation in the country is that of the Influenza B/Victoria strain.
The Ministry of Health and Medical Services say this may be the likely cause of the second surge of influenza-like illnesses being reported and observed locally.
According to the ministry, its surveillance systems had shown the resurgence in reporting of influenza-like and acute respiratory illnesses since early December last year.
And earlier this year (2023), the ministry recorded an outbreak of a type of influenza type A virus scientifically labeled as FluA/H1 Pdm.
The ministry stated that this outbreak had receded.
“…However, we now have indications of another outbreak of flu-like illness. Essentially, we are observing a ‘double peak trend’ (bi-phasic) of influenza-like illness case reports over the last several months since December 2022.
“As observed from past years’ trends, Fiji’s influenza season usually runs from January to May-June annually.”
While confirming the Influenza B/Victoria strain in circulation, the ministry stated that the increased presence of influenza B in circulation “is similarly being observed in other countries of the region and the world”.
The ministry stated there was the Tamiflu antiviral medication stock being distributed.
“We are getting more flu vaccines, which will be offered to those vulnerable to the severe effects of influenza – individuals with chronic illness, pregnant women and frontline staff.
“Surveillance has also been escalated and we await more recent reports to determine ongoing trends.”
It said while it still had stocks of flu testing reagents and consumables, the ministry was also working with the World Health Organization (WHO) to increase its stocks.
The ministry had also advised members of the public to stay at home when feeling unwell or to wear face masks when going outside in order to minimise the spread of infection.
